Rhodia's Ops In Emerging Mkts At Yr Ago Levels -CEO
PARIS (Dow Jones)--French chemicals specialist Rhodia SA's (RHA.FR) activities in emerging economies have returned to pre-crisis levels, but even if the worst is over in Europe and North America there is sill no clear trend there, Chief Executive Jean-Pierre Clamadieu said in an interview with Dow Jones Newswires.
"At the end of the first half we are back where we were a year ago (in emerging countries). In America and Western Europe, the worst is behind us, but we are in a situation where we don't see clear trends that recovery is here yet," Clamadieu said.
He noted that in Asia, recovery in activity levels are being seen in China and Korea, while Japan is not showing the same signs. The other key emerging markets for Rhodia are in Latin America, most notably Brazil.
Rhodia, which operates in automotive, electronics, consumer goods and industrial markets, saw its revenues slide in the fourth quarter of 2008 and the first quarter of 2009 on a collapse in demand and as its customers deferred purchasing, opting instead to use up their inventories. Revenue in the first quarter totaled EUR920 million versus EUR1.19 billion for the same period in 2008.
Turning to Europe Clamadieu said, "we saw a gradual improvement from January to March in demand. Since March the situation (in Europe) is stable with some qualitative signs of improvement. This is mostly customers telling us they are coming to the end of destocking, but this has not materialized yet in a significant demand increase in orders or sales.
"I expect that in the third quarter we will see the actual impact of (the end of) destocking in the form of higher volumes," Clamadieu said. Still, he's cautious about the third quarter as it is not yet clear if Rhodia's customers will adjust their normal plant stoppages during the summer recess.
Europe and North America accounted for 57% of Rhodia's EUR4.76 billion total sales in 2008.
As for the fourth quarter, Clamadieu said the key question globally is whether there will be a significant recovery in consumption, but for the moment it is too early to say.
Due to poor visibility, chemical companies have been shy to give guidance for the full year, instead emphasizing cost cutting plans and cash generation.
Clamadieu said Rhodia is well positioned to achieve its objective of free cash flow in 2009 and is still on target to achieve EUR150 million of structural cost savings by 2011.
With the addition to short-term cost savings, he said total savings for 2009 would be "well in excess" of the EUR60 million target.
French peer Arkema (AKE.FR) targets EUR110 million in savings for 2009, while Germany's Lanxess AG (LXS.XE) is targeting savings of EUR250 million for 2009 and 2010 combined.
"Our EUR150 million cost saving plan fits well with our current view of the markets in which we operate. If things change (from our current analysis) we would adjust our cost savings plans," Clamadieu said.
At the end of April, Standard and Poor's cut Rhodia's long-term credit rating to BB- from BB and affirmed its B short-term credit rating to reflect its opinion that key cash flow metrics and free cash flow generation will be under pressure in 2009 and 2010.
At March 31 Rhodia had net financial debt of EUR1.32 billion. The debt consists mainly of OCEANE convertible bonds maturing in 2014 and floating rate notes due in 2013.
"Today we are under no pressure to start looking at refinancing the company," Clamadieu said, noting the company has around EUR500 million of cash on the balance sheet and around EUR600 million of undrawn credit lines.
"We have plenty of financial resources and don't see a need to raise new equity, unless there was a specific project for which equity was needed. But we don't have any particular projects at the moment which would require that," he added.
Rhodia surprised investors in January when it announced the acquisition of the privately held Canadian specialty surfactants manufacturer McIntyre Group Ltd. At the time, Rhodia described it as a bolt-on acquisition to extend its personal cleaning product range in the Novecare division.
Clamadieu told Dow Jones Rhodia would consider further bolt-on acquisitions and is screening for opportunities, but is cautious to carry out acquisitions at present. "We would wait for signs of things improving before moving to the actual execution of such acquisitions," he said.
Clamadieu said that he doesn't see a trend for large scale consolidation in the chemicals sector as a whole.
He said there is still a need for restructuring in the polyamide industry to ensure a return to a balance between supply and demand.
Rhodia's Polyamide division, which is its largest by revenue with EUR1.79 billion in 2008, posted a 28% fall in sales in the first quarter. It is the world's second largest producer of Polyamide 6.6, the main product in the division.
However, Clamadieu said a price war is not a reality at present.
"We continue to enjoy satisfactory pricing power in all of our businesses," he said. "I continue to think margins are key to ensure the sustainability of our business. My feeling today is that price increases will be successful," noting the company is currently increasing prices in some business lines. Rhodia's earnings receive a significant boost from the sale of Certified Emission Reductions, or CERs, acquired under the Kyoto Protocol's Clean Development Mechanism. In particular, Rhodia generates credits from projects to cut greenhouse gas emissions at plants in South Korea and Brazil.
However, when Standard & Poor's downgraded Rhodia's credit rating in April, it also said it was concerned carbon credit prices may remain low in 2009 and 2010.
Clamadieu said that although low industrial production is weighing on the CER price at the moment, Rhodia expects the market will be bullish in the long term. He also said Rhodia's experience in the business gives it opportunities beyond the sale of credits and it is looking to use its technical and regulatory experience to work with other companies on similar projects and acquire portfolios of credit.
In 2008, CERs contributed EUR158 million to Rhodia's 2008 Earnings Before Interest, Tax, Depreciation and Amortization, or Ebitda.
At the time of its first quarter results publication early May, Rhodia said it had hedged 70% of the volume of its 2009 CER carbon credits at EUR14.7 and it forecasts 13 million tons of carbon credits over the full year. On the BlueNext exchange CERs closed Friday up EUR0.04 at EUR11.92.
Concerning the announcement Monday of the acquisition of Econcern Group's participation in six pilot biogas production projects located in China and Vietnam, Clamadieu said it is a signal that the company intends to pursue biogas development.
"For us, this is one of the developments we see in the carbon business," Clamadieu said.
At 0853 GMT shares in Rhodia were down 13 cents or 2.5% at EUR4.98 in a lower Paris market. The stock has lost half of its value over the past 12 months but has recovered from March lows of close To EUR2